Skystar Bio-pharmaceutical Co. (fka SKBI)

[RealDutch]

The information to which Nasdaq referred was the conduct by the Company’s audit committee of an internal investigation into certain allegations, raised by the Company’s auditors, that the auditors had been presented by Company personnel with false bank documents relating to one bank account.

That has nothing to do with what I said. This after the fact. How the audit committee behaved AFTER the problem was detected.

Look, Nasdaq are as clueless as they come. Obviously the company investigated the matter, how else could they fire the employee?
What this is, or could be, is a corporate governance issue. At an earlier stage.